Mechanisms of thrombus formation.

This review is an account of recent advances in our understanding of the mechanisms of thrombus formation, with emphasis on two independent pathways: one involving primarily platelets and the other initiated by tissue factor.

[1]  A. Hafezi-Moghadam,et al.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.

[2]  Y. Takada,et al.  Cross-talk of integrin α3β1 and tissue factor in cell migration , 2004 .

[3]  M. Jacobs,et al.  Thromboembolism and the Role of Anticoagulation in the Fontan Patient , 2007, Pediatric Cardiology.

[4]  W. Williams,et al.  The Fontan procedure: analysis of cohorts and late complications , 2000, Cardiology in the Young.

[5]  E. Medico,et al.  The MET oncogene drives a genetic programme linking cancer to haemostasis , 2005, Nature.

[6]  G. Broze,et al.  Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor* , 1998, The Journal of Biological Chemistry.

[7]  S. Coughlin,et al.  A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. , 2008, The Journal of clinical investigation.

[8]  P. Carmeliet,et al.  Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis , 2001, Nature Medicine.

[9]  J. Loscalzo,et al.  In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Østerud.  The role of platelets in decrypting monocyte tissue factor. , 2001, Disease-a-month : DM.

[11]  G. Feuerstein,et al.  Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice , 2005, Journal of thrombosis and haemostasis : JTH.

[12]  T. Orfeo,et al.  The Factor V Activation Paradox* , 2004, Journal of Biological Chemistry.

[13]  R. Hynes,et al.  CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism , 2002, Nature Medicine.

[14]  V. Nachmias,et al.  Platelet activation. , 2020, Arteriosclerosis.

[15]  S. Goto,et al.  Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. , 1998, The Journal of clinical investigation.

[16]  Z. Ruggeri.  Old concepts and new developments in the study of platelet aggregation. , 2000, The Journal of clinical investigation.

[17]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al.  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[18]  S. Hazen,et al.  Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype , 2007, Nature Medicine.

[19]  Nigel Mackman,et al.  Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. , 2008, The Journal of clinical investigation.

[20]  K. Mann,et al.  The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. , 1979, The Journal of biological chemistry.

[21]  M. A. Wouters,et al.  Cross-strand disulphides in cell entry proteins: poised to act. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.

[23]  E. Davie,et al.  Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.

[24]  A. Wessel,et al.  Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis). , 2005, The Journal of thoracic and cardiovascular surgery.

[25]  R. Macfarlane.  An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier , 1964, Nature.

[26]  H. Versteeg,et al.  Tissue Factor Coagulant Function Is Enhanced by Protein-disulfide Isomerase Independent of Oxidoreductase Activity* , 2007, Journal of Biological Chemistry.

[27]  J. Chou,et al.  Leukocyte‐versus microparticle‐mediated tissue factor transfer during arteriolar thrombus development , 2005, Journal of leukocyte biology.

[28]  N. Hagiwara,et al.  Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[29]  N. Callander,et al.  Immunohistochemical identification of tissue factor in solid tumors , 1992, Cancer.

[30]  B. Furie,et al.  Molecular and cellular biology of blood coagulation. , 1992, The New England journal of medicine.

[31]  B. Nieswandt,et al.  Integrin α2-Deficient Mice Develop Normally, Are Fertile, but Display Partially Defective Platelet Interaction with Collagen* , 2002, The Journal of Biological Chemistry.

[32]  A. Lopes,et al.  Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operation , 2005, Cardiology in the Young.

[33]  V. Fuster,et al.  Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. , 2000, Journal of the American College of Cardiology.

[34]  B. Furie,et al.  Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. , 2008, Structure.

[35]  A. Mantovani,et al.  Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. , 1983, Immunology.

[36]  P. D. da Luz,et al.  Influence of Hypoxia on Nitric Oxide Synthase Activity and Gene Expression in Children With Congenital Heart Disease: A Novel Pathophysiological Adaptive Mechanism , 2001, Circulation.

[37]  H. Horigome,et al.  Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. , 2003, Thrombosis research.

[38]  J. D. Hellums,et al.  A New Role for P-Selectin in Shear-Induced Platelet Aggregation , 2000, Circulation.

[39]  R. Bertina,et al.  Microparticle-Associated Tissue Factor Activity: A Link between Cancer and Thrombosis?. , 2005 .

[40]  M. J. Broekman,et al.  COX inhibitors and thromboregulation. , 2002, The New England journal of medicine.

[41]  H. Liebman,et al.  Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. , 2003, Thrombosis research.

[42]  Nigel Mackman,et al.  Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. , 2004, Blood.

[43]  K. Mann,et al.  Tissue factor activity in whole blood. , 2005, Blood.

[44]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Yow,et al.  Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial , 2008, Circulation.

[46]  P. Hogg,et al.  Allosteric disulfide bonds in thrombosis and thrombolysis , 2006, Journal of thrombosis and haemostasis : JTH.

[47]  T. Renné,et al.  Defective thrombus formation in mice lacking coagulation factor XII , 2005, The Journal of experimental medicine.

[48]  G. Shaw,et al.  Characterization of the Novel P-Selectin Inhibitor PSI-697 [2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] Quinoline-4-carboxylic acid] in Vitro and in Rodent Models of Vascular Inflammation and Thrombosis , 2008, Journal of Pharmacology and Experimental Therapeutics.

[49]  Samin K. Sharma,et al.  Identification of active tissue factor in human coronary atheroma. , 1996, Circulation.

[50]  H. Horigome,et al.  Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. , 2002, Journal of the American College of Cardiology.

[51]  B. Furie,et al.  Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. , 2007, The Journal of clinical investigation.

[52]  F. Taylor,et al.  Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis. , 2005, The American journal of pathology.

[53]  B. Østerud.  The role of platelets in decrypting monocyte tissue factor. , 2001, Seminars in hematology.

[54]  D. Essex,et al.  Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. , 2001, Biochemistry.

[55]  K. Kario,et al.  'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[56]  Y. Nemerson,et al.  Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. , 2004, Blood.

[57]  C. Sáez,et al.  Human platelets synthesize and express functional tissue factor. , 2007, Blood.

[58]  P. Carmeliet,et al.  Regulation of angiogenesis by tissue factor cytoplasmic domain signaling , 2004, Nature Medicine.

[59]  Y. Nemerson,et al.  Association of tissue factor activity with the surface of cultured cells. , 1975, The Journal of clinical investigation.

[60]  L. Greenfield,et al.  Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. , 1997, Journal of vascular surgery.

[61]  N. Ammash,et al.  Cerebrovascular events in adult patients with cyanotic congenital heart disease. , 1996, Journal of the American College of Cardiology.

[62]  J. Ritter,et al.  Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease. , 1993, British heart journal.

[63]  M. J. Broekman,et al.  Role of CD39 (NTPDase-1) in Thromboregulation, Cerebroprotection, and Cardioprotection , 2005, Seminars in thrombosis and hemostasis.

[64]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation , 1993 .

[65]  K. Hotchkiss,et al.  Physical Proximity and Functional Association of Glycoprotein 1bα and Protein-disulfide Isomerase on the Platelet Plasma Membrane* , 2000, The Journal of Biological Chemistry.

[66]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[67]  B. Furie,et al.  Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. , 2006, Blood.

[68]  N. Prévost,et al.  Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Mayer,et al.  Long-term results of the lateral tunnel Fontan operation. , 2001, The Journal of thoracic and cardiovascular surgery.

[70]  P. Hanrath,et al.  Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches. , 2002, The Annals of thoracic surgery.

[71]  B. Osterud,et al.  Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. A. Ali Khan,et al.  Results of 546 Blalock-Taussig shunts performed in 478 patients , 1998, Cardiology in the Young.

[73]  D. Tanné,et al.  Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. , 2008, Blood.

[74]  P. Fay,et al.  Regulation of blood coagulation by the protein C system , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[76]  U. Rauch,et al.  Tissue factor-positive microparticles in blood associated with coagulopathy in cancer , 2006, Thrombosis and Haemostasis.

[77]  Thomas Orfeo,et al.  The Tissue Factor Requirement in Blood Coagulation* , 2005, Journal of Biological Chemistry.

[78]  J. Badimón,et al.  Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[79]  S. Coughlin,et al.  Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis , 2007, Proceedings of the National Academy of Sciences.

[80]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[81]  H. Versteeg,et al.  Evidence for activation of tissue factor by an allosteric disulfide bond. , 2006, Biochemistry.

[82]  E. Bae,et al.  Impaired vascular function in patients with Fontan circulation. , 2007, International journal of cardiology.

[83]  J. Freyssinet,et al.  Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. , 1999, Blood.

[84]  S. Yamamoto,et al.  Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. , 1987, The EMBO journal.

[85]  A. Wessel,et al.  Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving Aspirin , 1999, Cardiology in the Young.

[86]  L. Brass,et al.  Minding the gaps to promote thrombus growth and stability. , 2005, The Journal of clinical investigation.

[87]  S. Jackson,et al.  Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency. , 2006, Blood.

[88]  D. Seiffert,et al.  Feedback activation of factor XI by thrombin does not occur in plasma , 2007, Proceedings of the National Academy of Sciences.

[89]  J. Chou,et al.  Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.

[90]  J. W. Wong,et al.  Allosteric Disulfide Bonds , 2006 .

[91]  Y. Cheung,et al.  Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure. , 2005, International journal of cardiology.

[92]  D. Rifkin,et al.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[93]  R. Cotran,et al.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.

[94]  D. Wagner,et al.  The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis , 2006, Proceedings of the National Academy of Sciences.

[95]  K. Jurk,et al.  Platelets: Physiology and Biochemistry , 2005, Seminars in thrombosis and hemostasis.

[96]  M. O’Donnell,et al.  Beyond Unfractionated Heparin and Warfarin: Current and Future Advances , 2007, Circulation.

[97]  M. Hori,et al.  Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. , 1998, Circulation.

[98]  J. Freyssinet,et al.  Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[99]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. , 1993, Blood.

[100]  L. Greenfield,et al.  P-Selectin Antagonism Causes Dose-dependent Venous Thrombosis Inhibition , 2001, Thrombosis and Haemostasis.

[101]  J. Weisel,et al.  Long range propagation of conformational changes in integrin alpha IIb beta 3. , 1993, The Journal of biological chemistry.

[102]  T. Renné,et al.  Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis , 2006, The Journal of experimental medicine.

[103]  C. Benjamin,et al.  Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets , 1992, Nature.

[104]  M J Davies,et al.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.

[105]  S. Eichinger,et al.  Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer , 2006, Thrombosis and Haemostasis.

[106]  D. Devine,et al.  Hemostatic Parameters and Platelet Activation Marker Expression in Cyanotic and Acyanotic Pediatric Patients Undergoing Cardiac Surgery in the Presence of Tranexamic Acid , 2000, Thrombosis and Haemostasis.

[107]  G. Davı̀,et al.  Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.

[108]  G. Nelsestuen,et al.  Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor. , 2005, Biochemistry.

[109]  DavidGailani,et al.  Intrinsic Pathway of Coagulation and Arterial Thrombosis , 2007 .

[110]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[111]  J. Spivak,et al.  Commentary on and reprint of Davie EW, Ratnoff OD, Waterfall sequence for intrinsic blood clotting, in Science (1964) 145:1310–1311 , 2000 .

[112]  U. Heinzmann,et al.  A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo , 2003, The Journal of experimental medicine.

[113]  K. Clauser,et al.  Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. , 2005, Blood.

[114]  J. Piette,et al.  Plasma levels of thrombomodulin in pulmonary hypertension. , 1996, The American journal of medicine.

[115]  Thomas N. Sato,et al.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. , 2000, The Journal of clinical investigation.

[116]  J. Freyssinet,et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.

[117]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[118]  J. Folkman,et al.  Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.

[119]  D. Dietzen,et al.  Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. , 2004, Blood.

[120]  T. Renné,et al.  Intrinsic Pathway of Coagulation and Arterial Thrombosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[121]  P. Carmeliet,et al.  Role of tissue factor in embryonic blood vessel development , 1996, Nature.

[122]  B. Nieswandt,et al.  Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen , 2001 .

[123]  F. Kirkham,et al.  Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[124]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[125]  S. Gordon,et al.  A factor X-activating cysteine protease from malignant tissue. , 1981, The Journal of clinical investigation.

[126]  A. Marelli,et al.  Risk of Stroke in Adults With Cyanotic Congenital Heart Disease , 1993, Circulation.

[127]  C. Silversides,et al.  Pulmonary thrombosis in adults with Eisenmenger syndrome. , 2003, Journal of the American College of Cardiology.